Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Bajaj Healthcare
Small Cap•1,049 Employees•IPO 2016
Current Price
₹283.95
-16.5 (-5.49%)Updated
Today's Range
282.15
₹283.95
300.4
52 Week Range
52W Low₹300.00
52W High₹745.00
₹283.95
Downside-5.35%
Upside162.37%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹1,134.15 Cr
Market Cap
Total market value of companyP/E Ratio
22.78
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
3.15
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹15.36
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
4.68%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
11.40%
ROCE
Return on Capital Employed. >15% is goodNet Margin
8.13%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
7.48%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
5.76%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
11.10%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
49.30%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.48
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹147.60
Book Value
Net asset value per shareDividend Yield
0.26%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
59.20%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Robust 49.30% quarterly profit growth indicates strong recent operational performance.
- •Healthy debt-to-equity ratio of 0.48 indicates manageable leverage and lower financial risk.
Weaknesses
5 points- •Significant decrease in promoter holding to 59.2% may signal reduced confidence.
- •Low Return on Equity (ROE) of 10.70% compared to industry peers.
Opportunities
5 points- •Expanding Pharmaceuticals and Healthcare sector provides favorable environment for increased demand.
- •Smaller market cap (1411 Cr) offers significant scope for market expansion.
Threats
4 points- •Highly competitive pharmaceutical sector with larger players poses significant market challenges.
- •Stringent, evolving healthcare regulations could impact operational costs and product approvals.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
Recent Insider Transactions
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
SAJANKUMAR RAMESHWARLAL BAJAJ | 04 Feb 2025 | 07 Feb 2025 | 1.19 Cr | 21.60 L | - | BUY |
SKR BAJAJ HUF | 04 Feb 2025 | 07 Feb 2025 | - | 21.60 L | - | SELL |
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹332.02 | +₹48.07 | +16.93% |
| R3 | ₹313.77 | +₹29.82 | +10.50% |
| R2 | ₹307.08 | +₹23.13 | +8.15% |
| R1 | ₹295.52 | +₹11.57 | +4.07% |
| PIVOT | ₹288.83 | 4.88 | 1.72% |
| CURRENT | ₹283.95 | - | - |
| S1 | ₹240.77 | -₹43.18 | -15.21% |
| S2 | ₹259.02 | -₹24.93 | -8.78% |
| S3 | ₹270.58 | -₹13.37 | -4.71% |
| S4 | ₹277.27 | -₹6.68 | -2.35% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+105.7% vs avg
3.35L
(13 Mar 2026)Delivery %+25.4% vs avg
66.2%
(13 Mar 2026)Avg Volume (20D)20-day average
1.63L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
40.9%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Wanbury Ltd
1197.00 %
Highest Dividend Yield
Jagsonpal Pharmaceuticals Ltd
1.44 %
Peer Comparison
| Company Name |
|---|
 Beta Drugs Ltd |
 Bliss GVS Pharma Ltd |
 Ind-Swift Laboratories Ltd |
 Jagsonpal Pharmaceuticals Ltd |
 Lincoln Pharmaceuticals Ltd |
 NGL Fine Chem Ltd |
 Sakar Healthcare Ltd |
 Sigachi Industries Ltd |
 Sun Pharmaceutical Industries Ltd |
 Syncom Formulations (India) Ltd |
 Themis Medicare Ltd |
 TTK Healthcare Ltd |
 Venus Remedies Ltd |
 Wanbury Ltd |
About
Bajaj Healthcare Ltd
Bajaj HealthCare Limited is an Indian pharmaceutical company established in 1993 and headquartered in Thane. Its core business revolves around the development, manufacturing, marketing, and sale of pharmaceutical products across India and internationally. Their offerings span a wide range, catering to the pharmaceutical, nutraceutical, and food industries.
A significant portion of their business involves the production and supply of active pharmaceutical ingredients (APIs). These APIs cover a broad spectrum of therapeutic categories, including treatments for diabetes, infections (antibiotic, antiviral, antifungal), cardiovascular issues, respiratory ailments (anti-asthmatic, bronchodilator), and many others. The extensive list of therapeutic areas indicates a diverse portfolio designed to meet varied market demands.
Beyond APIs, Bajaj HealthCare also manufactures and provides pharmaceutical intermediates. These are crucial chemical compounds used in the synthesis of APIs. The company's production of intermediates demonstrates vertical integration within the pharmaceutical supply chain, allowing for greater control over quality and potentially reducing costs.
Finally, Bajaj HealthCare produces finished dosage forms, offering a variety of formulations such as tablets, capsules, sachets, and vials. This provides a complete solution to customers, offering both the raw materials and the final products. The inclusion of nutraceuticals and food supplements further diversifies their product offerings and expands their market reach.
In summary, Bajaj HealthCare operates as a fully integrated pharmaceutical company, from the production of basic intermediates to the manufacturing and distribution of finished pharmaceutical and nutraceutical products. Their broad therapeutic coverage and diverse product portfolio position them within a competitive market.
COMPANY FACTS - BAJAJHCARE
Registered Address
602-606, Bhoomi Velocity, Plot No. B-39, B-39A, B-39A/1, Road No.23,Wagle Industrial Estate
Thane
MAHARASHTRA
IN
Tel: 912240177400
Website:https://www.bajajhealth.com/
Investor Relations:http://www.bajajhealth.com/stock-exchange-intimation-2021-22/
Company Details
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 1,049
IPO Date: 10/05/2016
MANAGEMENT - BAJAJHCARE
Mr. Sajankumar Bajaj
Executive Chairman of the Board, Managing Director
Mr. Amit Rajan
Chief Technology Officer
Mr. Anil Jain
Joint Managing Director, Executive Director
Ms. Namrata Bajaj
Whole Time Director
Mr. Pakshal Jain
Whole Time Director
Mr. Sandeep Shah
Non-Executive Non-Independent Director
Mr. Ram Banarse
Non-Executive Independent Director
Mr. Hemant Karnik
Non-Executive Independent Director
Mr. Gopalakrishnan Kesavan
Additional Non-Executive Independent Director
Mrs. Kejal Shah
Non-Executive Independent Director
Mr. Loukik Tipnis
Non-Executive Independent Director
Investor Questions Answered
Bajaj Healthcare Ltd (BAJAJHCARE) Stock FAQs
Get answers to the most common questions about Bajaj Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Bajaj Healthcare Ltd (BAJAJHCARE) is ₹283.95. Today, the stock has declined by ₹16.50 (5.49%), trading in a range of ₹282.15 to ₹300.4. The stock opened at ₹300.05 with a trading volume of 3,35,439 shares.
Bajaj Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,134.15 crores, P/E ratio of 22.78, ROE of 4.68%, and ROCE of 11.40%. The dividend yield stands at 0.26%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Bajaj Healthcare Ltd (BAJAJHCARE) is ₹745, while the 52-week low is ₹300. Currently trading at ₹283.95, the stock is -3.6% away from its 52-week low and 61.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Bajaj Healthcare Ltd stock at ₹283.95 depends on multiple factors. The stock is currently trading with a P/E ratio of 22.78 and P/B ratio of N/A. Today's performance shows a loss of 5.49%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Bajaj Healthcare Ltd offers a dividend yield of 0.26%, which means for every ₹100 invested at the current price of ₹283.95, you can expect to receive approximately ₹0.26 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Bajaj Healthcare Ltd's key financial metrics include: P/E Ratio: 22.78, P/B Ratio: N/A, ROE: 4.68%, ROCE: 11.40%, Dividend Yield: 0.26%, EPS: ₹15.36, Book Value: ₹147.6, Debt-to-Equity: 0.48, and Current Ratio: N/A. The company's market cap stands at ₹1,134.15 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Bajaj Healthcare Ltd stock opened at ₹300.05 and is currently trading at ₹283.95, showing a decline of ₹16.50 (5.49%). The intraday high is ₹300.4 and low is ₹282.15. The trading volume stands at 3,35,439 shares, indicating moderate market participation today.
Bajaj Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 22.78, which means investors are willing to pay ₹22.78 for every ₹1 of earnings. With an EPS of ₹15.36, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Bajaj Healthcare Ltd has a market capitalization of ₹1,134.15 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹283.95) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Bajaj Healthcare Ltd has a book value of ₹147.6 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹283.95, which is 92.4% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Bajaj Healthcare Ltd has a Return on Equity (ROE) of 4.68% and Return on Capital Employed (ROCE) of 11.40%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Bajaj Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Bajaj Healthcare Ltd has a debt-to-equity ratio of 0.48, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Bajaj Healthcare Ltd has an Earnings Per Share (EPS) of ₹15.36, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹283.95 and P/E ratio of 22.78, investors are paying 22.78 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Bajaj Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Bajaj Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Bajaj Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (22.78), ROE (4.68%), debt-to-equity (0.48), and growth rates. 2) Technical Analysis - Check 52-week range (₹300.00 - ₹745.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹283.95) with book value (₹147.60) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Bajaj Healthcare Ltd share is ₹5.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹283.95 is 5579x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Bajaj Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹300.00 - ₹745.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.48 indicates leverage. 4) Liquidity Risk - Based on trading volume of 3,35,439 shares. 5) Valuation Risk - P/E of 22.78 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Bajaj Healthcare Ltd operates in the industry with key metrics: P/E ratio of 22.78, ROE of 4.68%, market cap of ₹1,134.15 crores, and dividend yield of 0.26%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.48), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Bajaj Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹283.95, with a 52-week range of ₹300.00 to ₹745.00. Based on fundamentals like P/E (22.78), ROE (4.68%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Bajaj Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹283.95. 2) Fundamental Deterioration - Declining ROE (currently 4.68%), increasing debt (D/E: 0.48), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Bajaj Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.26%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu